关注
Blaine Pfeifer
Blaine Pfeifer
Professor of Chemical and Biological Engineering, SUNY-Buffalo
在 buffalo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli
PK Ajikumar, WH Xiao, KEJ Tyo, Y Wang, F Simeon, E Leonard, O Mucha, ...
Science 330 (6000), 70-74, 2010
19002010
Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli
BA Pfeifer, SJ Admiraal, H Gramajo, DE Cane, C Khosla
Science 291 (5509), 1790-1792, 2001
9482001
Overcoming nonviral gene delivery barriers: perspective and future
CH Jones, CK Chen, A Ravikrishnan, S Rane, BA Pfeifer
Molecular pharmaceutics 10 (11), 4082-4098, 2013
4432013
Biosynthesis of polyketides in heterologous hosts
BA Pfeifer, C Khosla
Microbiology and Molecular Biology Reviews 65 (1), 106-118, 2001
3872001
Porphyrin–phospholipid liposomes permeabilized by near-infrared light
KA Carter, S Shao, MI Hoopes, D Luo, B Ahsan, VM Grigoryants, W Song, ...
Nature communications 5 (1), 3546, 2014
3382014
Methods and options for the heterologous production of complex natural products
H Zhang, BA Boghigian, J Armando, BA Pfeifer
Natural product reports 28 (1), 125-151, 2011
1792011
Overcoming gene-delivery hurdles: physiological considerations for nonviral vectors
AB Hill, M Chen, CK Chen, BA Pfeifer, CH Jones
Trends in biotechnology 34 (2), 91-105, 2016
1702016
Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host
H Zhang, Y Wang, J Wu, K Skalina, BA Pfeifer
Chemistry & biology 17 (11), 1232-1240, 2010
1602010
Biosynthesis of Yersiniabactin, a Complex Polyketide-Nonribosomal Peptide, Using Escherichia coli as a Heterologous Host
BA Pfeifer, CCC Wang, CT Walsh, C Khosla
Applied and environmental microbiology 69 (11), 6698-6702, 2003
1542003
Metabolic flux analysis and pharmaceutical production
BA Boghigian, G Seth, R Kiss, BA Pfeifer
Metabolic engineering 12 (2), 81-95, 2010
1432010
Bacterial hosts for natural product production
H Zhang, Y Wang, BA Pfeifer
Molecular pharmaceutics 5 (2), 212-225, 2008
1412008
Metabolic Engineering of a Methylmalonyl-CoA Mutase−Epimerase Pathway for Complex Polyketide Biosynthesis in Escherichia coli,
LC Dayem, JR Carney, DV Santi, BA Pfeifer, C Khosla, JT Kealey
Biochemistry 41 (16), 5193-5201, 2002
1262002
Process and Metabolic Strategies for Improved Production of Escherichia coli-Derived 6-Deoxyerythronolide B
B Pfeifer, Z Hu, P Licari, C Khosla
Applied and environmental microbiology 68 (7), 3287-3292, 2002
1182002
Poly (ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery
CK Chen, CH Jones, P Mistriotis, Y Yu, X Ma, A Ravikrishnan, M Jiang, ...
Biomaterials 34 (37), 9688-9699, 2013
782013
Synthesis of cationic polylactides with tunable charge densities as nanocarriers for effective gene delivery
CH Jones, CK Chen, M Jiang, L Fang, C Cheng, BA Pfeifer
Molecular pharmaceutics 10 (3), 1138-1145, 2013
752013
Investigating the role of native propionylCoA and methylmalonylCoA metabolism on heterologous polyketide production in Escherichia coli
H Zhang, BA Boghigian, BA Pfeifer
Biotechnology and bioengineering 105 (3), 567-573, 2010
732010
Enhancing the atom economy of polyketide biosynthetic processes through metabolic engineering
F Lombó, B Pfeifer, T Leaf, S Ou, YS Kim, DE Cane, P Licari, C Khosla
Biotechnology progress 17 (4), 612-617, 2001
722001
Phenotypic variation during biofilm formation: implications for anti-biofilm therapeutic design
M Beitelshees, A Hill, CH Jones, BA Pfeifer
Materials 11 (7), 1086, 2018
702018
Formulation and surface modification of poly (ester-anhydride) micro-and nanospheres
BA Pfeifer, JA Burdick, R Langer
Biomaterials 26 (2), 117-124, 2005
672005
Synthesis of pH-Responsive Chitosan Nanocapsules for Controlled Delivery of Doxorubicin.
CC Chen CK, Wang Q, Jones CH, Yu Y, Zhang H, Law WC
Langmuir, 2014
662014
系统目前无法执行此操作,请稍后再试。
文章 1–20